Anticoagulants and Antiplatelets Flashcards
Know the factors common to both the intrinsic and extrinsic pathways of coagulation.
X, V, II (prothrombin: activated to IIa: thrombin), I (fibrinogen; activated to Ia: fibrin)
Four dependent on Vit K: II, VII, IX, X
Heparin effects what part of the clotting cascade?
Main therapeutic affect on factors Xa and IIa
How is heparin monitored?
Monitor anticoagulant effects via aPTT, anti-factor Xa assay, or heparin levels
What are the Indications for Heparin?
PE and DVT treatment and prophylaxis
ACS – use depends on NSTEMI vs. STEMI and management strategy (PCI vs. medical); dosing protocols
Side effects of Heparin:
Heparin induced thrombocytopenia can occur (HIT)
Long-term use may increase risk for osteoporosis
Heparin is completely reversed by _________.
protamine sulfate
T/F: Heparin does not require continual monitoring.
False, Inconsistent effects require monitoring
_________ is the Anticoagulant of choice in severe renal dysfunction.
Heparin
How is Heparin eliminated?
Eliminated via Reticuloendothelial system, not by kidneys
How do we monitor Warfarin and what is the goal?
Monitor with INR; Normal: 0.9 – 1.1, goal: 2-3 (mitral valve replacement, 2.5-3.5)
What are the indications for warfarin?
DVT, PE, antiphospholipid syndrome, atrial fibrillation, protein C/S deficiency, mechanical valve replacement, etc.
Pearls of Warfarin:
Holding a dose often reduces INR by 0.5 – 1 point
Efficacious, cheap, old and known, no renal adjustments
How long does it take for the therapeutic effects of warfarin? What is the adjustment based on?
Therapeutic effects take 2-3 days to start, 5-7 days for full effects. Loading only minimally effective. Adjust based on total weekly dose (TWD) by 10-20%. Monitor INR weekly until stable and then increase interval.
What is the antidote of warfarin?
“Antidote” is vitamin K. PCC, FFP, platelets also given in cases of bleeding.
Warfarin has ___________ benefits.
Cardioprotective benefits
What is Dabigatran (Pradaxa)
Direct thrombin (IIa) inhibitor (ANTI-PLATELET).